The Use of Probiotics in the Prevention and Treatment of Antibiotic‐Associated Diarrhea With Special Interest in Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Antimicrobials are effective agents used to combat virulent bacterial, yeast, and fungal infections that may otherwise cause rampant disease leading to skyrocketing social/economic costs and possible epidemic morbidity and mortality rates. Antibiotics are designed to attack specific bacterial pathogens but, in the process, indiscreetly reduce the number of beneficial human microbiota that is part of the gut‐associated lymphatic tissue. Broad‐spectrum antibiotics can upset this uniquely balanced gut ratio, allowing pathogens to propagate in a largely unrestrained environment, which may result in antibiotic‐induced diarrhea. Critical illness, age, immunosuppression, exposure to nosocomial microorganisms, and the length of hospitalization are additional factors that contribute to the overgrowth of opportunistic pathogens. In mild to moderate cases of diarrhea, absorptive impairment may occur, thereby reducing micro/macronutrient assimilation, resulting in malnutrition and growth issues in children. In severe cases, infectious diarrhea can have devastating complications. Of particular interest is the bacterium Clostridium difficile, which has the potential to cause a host of symptoms ranging from mild diarrhea to severe life‐threatening conditions. C. difficile infection can increase mortality rates by 10%–30%. Probiotic supplementation may prevent and treat antibiotic‐associated diarrhea. Specific probiotics may modulate the intestinal mucosa by antagonizing pathogens through the production of antimicrobial compounds and chemicals, thereby reducing the rate of nosocomial infection and recurrence of C. difficile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Probiotics and their fermented food products are beneficial for health
Parvez, S., Malik, K. A., Ah Kang, S., & Kim, H.-Y. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02963.x · Cited by 1,435
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 7×
“Three variations of this definition include the Bristol stool form scale, King’s stool chart, and defining diarrhea as more than 3 loose bowel movements a day for at least 2 days.(14,39) King’s stool chart demonstrated construct validity for the characterization of fecal frequency, weight, and consistency and may be a…”
BackgroundMethodInfluentialProbiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776 · cited 16×
“In addition, standardized criteria must be designed to increase the validity of the test results.(10) Prevention remains the best defense against the incidence of AAD and CDAD.”
BackgroundInfluentialHickson, M., D'Souza, A. L., Muthu, N., Rogers, T. R., Want, S., Rajkumar, C., & Bulpitt, C. J. (2007) · BMJ · doi:10.1136/bmj.39231.599815.55 · Cited by 599
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 2×
“This included malignancies or serious GI disorders.(37) In a study by Salminen and associates(12,37) in Finland, the average incidence of Lactobacillus bacteremia was 0.”
BackgroundProbiotics and Prebiotics: Effects on Diarrhea1
de Vrese, M., & Marteau, P. R. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.803s · Cited by 312 · cited 1×
“The effects of probiotics on humans have been assessed mainly in small, randomized, controlled clinical studies.(42) Most of the studies to date have been done in acute care facilities without control of key variants such as study populations, type and dose of probiotic used, duration of treatment (5 days to 8 weeks),…”
Background
Cited by
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
Hill, D. A., Hoffmann, C., Abt, M. C., Du, Y., Kobuley, D., Kirn, T. J., Bushman, F. D., & Artis, D. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.132 · Cited by 431
Gao, X. W., Mubasher, M., Fang, C. Y., Reifer, C., & Miller, L. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.11 · Cited by 318
The “psychomicrobiotic”: targeting microbiota in major psychiatric disorders: a systematic review
Fond, G., Boukouaci, W., Chevalier, G., Regnault, A., Eberl, G., Hamdani, N., Dickerson, F., Macgregor, A., Boyer, L., Dargel, A., et al. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2014.10.003 · Cited by 219
Regulatory Oversight and Safety of Probiotic Use
Venugopalan, V., Shriner, K. A., & Wong-Beringer, A. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1611.100574 · Cited by 216
Metadata
- Authors
- Rohde, C. L., Bartolini, V., & Jones, N.
- Venue
- Nutrition in Clinical Practice
- Publisher
- Wiley
- Published
- 2009-02
- Volume
- 24
- Issue
- 1
- Pages
- 33-40
- ISSN
- 0884-5336 (ISSN-L)
- 1941-2452
- OpenAlex
- W2028190435
- Cited by
- 74
- References
- 6
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Use of Probiotics in the Prevention and Treatment of Antibiotic‐Associated Diarrhea With Special Interest in Clostridium difficile–Associated Diarrhea. https://app.cochat.ai/papers/10.1177/0884533608329297
- The paper
- Rohde, C. L., Bartolini, V., & Jones, N. (2009). The Use of Probiotics in the Prevention and Treatment of Antibiotic‐Associated Diarrhea With Special Interest in Clostridium difficile–Associated Diarrhea. Nutrition in Clinical Practice. https://doi.org/10.1177/0884533608329297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.